Black Diamond Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BDTX and other ETFs, options, and stocks.About BDTX
Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type-mediated toxicities, and be brain-penetrant to treat central nervous system diseases.
BDTX Key Statistics
Stock Snapshot
Black Diamond Therapeutics(BDTX) stock is priced at $2.94, giving the company a market capitalization of 168.18M. It carries a P/E multiple of -3.95.
On 2026-05-11, Black Diamond Therapeutics(BDTX) stock moved within a range of $2.93 to $3.18. With shares now at $2.94, the stock is trading +0.3% above its intraday low and -7.7% below the session's peak.
Trading activity shows a volume of 1.03M, compared to an average daily volume of 954.85K.
The stock's 52-week range extends from a low of $1.61 to a high of $4.94.
The stock's 52-week range extends from a low of $1.61 to a high of $4.94.
Analyst ratings
89%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.